[go: up one dir, main page]

WO1999002566A3 - Proteine normalisee - Google Patents

Proteine normalisee Download PDF

Info

Publication number
WO1999002566A3
WO1999002566A3 PCT/EP1998/004237 EP9804237W WO9902566A3 WO 1999002566 A3 WO1999002566 A3 WO 1999002566A3 EP 9804237 W EP9804237 W EP 9804237W WO 9902566 A3 WO9902566 A3 WO 9902566A3
Authority
WO
WIPO (PCT)
Prior art keywords
binding site
standardised
specific binding
protein
antibody constant
Prior art date
Application number
PCT/EP1998/004237
Other languages
German (de)
English (en)
Other versions
WO1999002566A2 (fr
Inventor
Jochen Uhlenkueken
Gerd Schmidt
Manfred Lansing
Original Assignee
Jochen Uhlenkueken
Gerd Schmidt
Manfred Lansing
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jochen Uhlenkueken, Gerd Schmidt, Manfred Lansing filed Critical Jochen Uhlenkueken
Publication of WO1999002566A2 publication Critical patent/WO1999002566A2/fr
Publication of WO1999002566A3 publication Critical patent/WO1999002566A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

L'invention concerne une protéine normalisée caractérisée en ce qu'elle présente au moins un site de liaison spécifique pour des enzymes, et/ou un site de liaison spécifique pour la région constante d'un anticorps et/ou un site de liaison spécifique qui comprend les fragments de régions constantes d'anticorps, le site de liaison étant fonctionnel après une séparation électrophorétique réalisée dans des conditions dénaturantes.
PCT/EP1998/004237 1997-07-09 1998-07-08 Proteine normalisee WO1999002566A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19729248.8 1997-07-09
DE1997129248 DE19729248C1 (de) 1997-07-09 1997-07-09 Standardprotein

Publications (2)

Publication Number Publication Date
WO1999002566A2 WO1999002566A2 (fr) 1999-01-21
WO1999002566A3 true WO1999002566A3 (fr) 1999-04-01

Family

ID=7835079

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1998/004237 WO1999002566A2 (fr) 1997-07-09 1998-07-08 Proteine normalisee

Country Status (2)

Country Link
DE (1) DE19729248C1 (fr)
WO (1) WO1999002566A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998030684A1 (fr) 1997-01-08 1998-07-16 Life Technologies, Inc. Procedes de production de proteines
DE29900214U1 (de) * 1999-01-09 1999-08-12 Biosens Gesellschaft für Diagnostika mbH, 82041 Oberhaching Western-Blot-Streifen mit Kontrollzonen
DE10017526B4 (de) * 1999-04-08 2013-05-29 Jochen Uhlenküken Standardprotein
EP1054061A1 (fr) * 1999-05-18 2000-11-22 Jochen Uhlenküken Standard protéique comprenant au moins un domaine liant les anticorps de la protéine G de Streptocoque
IT1318400B1 (it) * 2000-03-17 2003-08-25 Dompe Spa Markers di massa molecolare per westner blot.
EP1236738A1 (fr) * 2001-02-23 2002-09-04 Jungbauer, Alois, Professor Dr. Standard interne pour des procédés de séparation électrophorétiques et chromatographiques
US7781173B2 (en) 2003-09-25 2010-08-24 Life Technologies Corporation Homogeneous populations of molecules
WO2005114220A2 (fr) * 2004-05-17 2005-12-01 Invitrogen Corporation Compositions, trousses et methodes pour etalonnage en spectrometrie de masse

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4356072A (en) * 1978-05-31 1982-10-26 Oriental Yeast Company Isoelectric point marker
US4507233A (en) * 1981-04-22 1985-03-26 Oriental Yeast Co., Ltd. Colored molecular weight marker
WO1986006383A1 (fr) * 1985-05-01 1986-11-06 Commonwealth Serum Laboratories Commission Determination du poids moleculaire de proteines
EP0550771A1 (fr) * 1991-07-25 1993-07-14 Oriental Yeast Co., Ltd. Proteine artificielle de combinaison avec les immunoglobulines
US5506121A (en) * 1992-11-03 1996-04-09 Institut Fur Bioanalytik Gemeinnutzige Gesellschaft MBH Fusion peptides with binding activity for streptavidin

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4356072A (en) * 1978-05-31 1982-10-26 Oriental Yeast Company Isoelectric point marker
US4507233A (en) * 1981-04-22 1985-03-26 Oriental Yeast Co., Ltd. Colored molecular weight marker
WO1986006383A1 (fr) * 1985-05-01 1986-11-06 Commonwealth Serum Laboratories Commission Determination du poids moleculaire de proteines
EP0550771A1 (fr) * 1991-07-25 1993-07-14 Oriental Yeast Co., Ltd. Proteine artificielle de combinaison avec les immunoglobulines
US5506121A (en) * 1992-11-03 1996-04-09 Institut Fur Bioanalytik Gemeinnutzige Gesellschaft MBH Fusion peptides with binding activity for streptavidin

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
LINDBLADH C. ET AL.: "STANDARD CALIBRATION PROTEINS FOR WESTERN BLOTTING OBTAINED BY GENETICALLY PREPARED PROTEIN A CONJUGATES", ANAL.BIOCHEM., vol. 197, 1991, pages 187 - 190, XP002087809 *
SAMUEL D. ET AL.: "A SENSITIVE METHOD OF DETECTING PROTEINS ON DOT AND WESTERN BLOTS USING A MONOCLONAL ANTIBODY TO FITC", J.IMMUNOL.METHODS, vol. 107, 1988, pages 217 - 224, XP002087810 *
ZUECO J. ET AL.: "PROTEIN A FUSION PROTEINS AS MOLECULAR WEIGHT MARKERS FOR USE IN IMMUNOBLOTTING", ANAL.BIOCHEM., vol. 207, 1992, pages 348 - 349, XP002087808 *

Also Published As

Publication number Publication date
DE19729248C1 (de) 1998-07-09
WO1999002566A2 (fr) 1999-01-21

Similar Documents

Publication Publication Date Title
AU5775696A (en) Automatic protein and/or dna analysis system and method
EP0807691A3 (fr) Procede de depistage d'une anomalie genetique associe a la trombose et/ou a une mauvaise reponse anticoagulante a la proteine c activee
AU3471697A (en) An improved method for the capillary electrophoresis of nucleic acids, proteins and low molecular charged compounds
AU6042699A (en) Assays for measuring nucleic acid binding proteins and enzyme activities
AU4567499A (en) Novel mtbx protein and nucleic acid molecules and uses therefor
WO1998013502A3 (fr) Procedes d'identification de composes pour la rupture des interactions entre proteines
IL131016A0 (en) Selection of proteins using rna-protein fusions
AU6213298A (en) Method and device for refining nucleic acids
AU3128000A (en) Peptidoglycan recognition proteins
WO1999020756A3 (fr) Homologues toll humains
PL338030A1 (en) Improved antibodies against ige and method of improving polypeptides
EP1255209A3 (fr) Dispositif et méthode permettant une mise au point informatisée de protéines
AU6402694A (en) Methods and materials relating to the functional domains of dna binding proteins
AU1686395A (en) (deltex) proteins, nucleic acids, and antibodies, and related methods and compositions
WO1999002566A3 (fr) Proteine normalisee
ES2232860T3 (es) Proteinas recombinantes de ribonucleasa.
AU5800696A (en) Rhesus ob protein and dna
AU1448295A (en) Assay employing both protein and antibody
AU5551299A (en) Method of identifying proteins
AU4553296A (en) Method and reagent for the specific determination of LDL in serum samples
EP0950663A4 (fr) Stabilisation de proteines utiles et compositions a base de proteines utiles
AU1655297A (en) Anti-Fas recombinant antibodies and DNA therefor
WO2000018909A3 (fr) Acides nucleiques et proteines provenant de cenarchaeum symbiosum
AU3451397A (en) Modified protein g and fragments thereof
AU1599299A (en) Methods and reagents for the utilization of sap family member proteins, novel signal transduction regulators

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): CA JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: CA

122 Ep: pct application non-entry in european phase